PPARA and metabolic dysfunction-associated steatohepatitis: Consistent with impaired hepatic fatty acid oxidation in non-alcoholic steatohepatitis (NASH), mRNA expression of PPARA is decreased in liver biopsies obtained from patients with NASH and inversely correlates with the severity of steatosis (7).